Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study
Purpose To compare daily ECG transmissions using trans-telephonic monitoring (TTM) with repeated 6-day Holter ECG in detecting atrial fibrillation (AF) episodes following ablation. Methods Each patient underwent two types of recordings: daily ECG TTM lasting 30 s and standard 6-day ambulatory ECG mo...
Gespeichert in:
| Veröffentlicht in: | Journal of interventional cardiac electrophysiology 2022-11, Vol.65 (2), p.373-380 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 380 |
|---|---|
| container_issue | 2 |
| container_start_page | 373 |
| container_title | Journal of interventional cardiac electrophysiology |
| container_volume | 65 |
| creator | Sikorska, Agnieszka Baran, Jakub Piotrowski, Roman Kryński, Tomasz Szymot, Joanna Soszyńska, Małgorzata Kułakowski, Piotr |
| description | Purpose
To compare daily ECG transmissions using trans-telephonic monitoring (TTM) with repeated 6-day Holter ECG in detecting atrial fibrillation (AF) episodes following ablation.
Methods
Each patient underwent two types of recordings: daily ECG TTM lasting 30 s and standard 6-day ambulatory ECG monitoring performed 3, 6, and 12 months after ablation. Number of patients with detected AF recurrences, time to first detected recurrence of AF, and AF burden were assessed.
Results
Fifty patients (9 females, mean age 57 ± 11 years) were included. The mean duration of the follow-up was 382 ± 38 days. A total of 17,573 (mean 351 ± 111 per patient) TTM recordings were performed and 99.95% of recordings were of quality sufficient to assess cardiac rhythm. Altogether, 14 (28%) patients had AF recurrence. Holter ECG detected AF recurrence in 7 (14%) patients whereas TTM — in 12 (24%) patients,
p
= 0.0416 (TTM only — 7 (14%), Holter ECG only — 2 (4%), and both methods — 5 (10%)). Time to the first AF recurrence tended to be shorter using TTM than Holter ECG (156 ± 91 vs 204 ± 121 days,
p
= 0.0819). There was no significant difference in AF burden assessed by TTM versus Holter ECG recordings 3.1 ± 0.14% vs 4.8 ± 0.2%,
p
= 0.21.
Conclusions
Compared with Holter ECG, daily 30-s ECG recordings detected more patients with AF recurrences. Time to first detected AF episode tended to be shorter using TTM. Daily ECG recordings transmitted using smartphone may replace standard Holter ECG in detecting AF after ablation.
Trial registration
Clinical Trials Identifier: NCT03877913 |
| doi_str_mv | 10.1007/s10840-022-01166-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8894837</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2732912005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-505badb3bf7cb89c62e9cd7e074a8c3e82b41af6edf5a5fe1a24d98f5f3c9fb13</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqXwAiyQJTZsDL7H2SBV02GKVMECkNhZjmO3rjJx8UkqZccjsOAJeRKcmaFcFqx85PP5s4__qnpKyUtKSP0KKNGCYMIYJpQqhcW96pjKmmEtG3m_1FxzrGv5-ah6BHBNCGkIUw-rIy6ZEJqR4-rbmY39jNarDRqzHWAbAWIa0K3PMAECn6PtkcKdndF56kefd2xIGY1XHlkAD7D1w4hSQD6E6Kybl9q2vR0X04LacacJsc2xP-z_-Pp9pzjdvFt_wIsUxqmbH1cPgu3BPzmsJ9WnN-uPq3N88X7zdnV6gZ2oxYglka3tWt6G2rW6cYr5xnW1J7Ww2nGvWSuoDcp3QVoZPLVMdI0OMnDXhJbyk-r13nsztVvfuTJCtr25yXFr82ySjebvzhCvzGW6NVo3QvO6CF4cBDl9mTyMpvyd82W8wacJDFNcUSGEYgV9_g96naY8lPEMqzlrKCNEFortKZcTQPbh7jGUmCVwsw_clMDNLnAjyqFnf45xd-RXwgXgewBKa7j0-ffd_9H-BFhKuYI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2732912005</pqid></control><display><type>article</type><title>Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Sikorska, Agnieszka ; Baran, Jakub ; Piotrowski, Roman ; Kryński, Tomasz ; Szymot, Joanna ; Soszyńska, Małgorzata ; Kułakowski, Piotr</creator><creatorcontrib>Sikorska, Agnieszka ; Baran, Jakub ; Piotrowski, Roman ; Kryński, Tomasz ; Szymot, Joanna ; Soszyńska, Małgorzata ; Kułakowski, Piotr</creatorcontrib><description>Purpose
To compare daily ECG transmissions using trans-telephonic monitoring (TTM) with repeated 6-day Holter ECG in detecting atrial fibrillation (AF) episodes following ablation.
Methods
Each patient underwent two types of recordings: daily ECG TTM lasting 30 s and standard 6-day ambulatory ECG monitoring performed 3, 6, and 12 months after ablation. Number of patients with detected AF recurrences, time to first detected recurrence of AF, and AF burden were assessed.
Results
Fifty patients (9 females, mean age 57 ± 11 years) were included. The mean duration of the follow-up was 382 ± 38 days. A total of 17,573 (mean 351 ± 111 per patient) TTM recordings were performed and 99.95% of recordings were of quality sufficient to assess cardiac rhythm. Altogether, 14 (28%) patients had AF recurrence. Holter ECG detected AF recurrence in 7 (14%) patients whereas TTM — in 12 (24%) patients,
p
= 0.0416 (TTM only — 7 (14%), Holter ECG only — 2 (4%), and both methods — 5 (10%)). Time to the first AF recurrence tended to be shorter using TTM than Holter ECG (156 ± 91 vs 204 ± 121 days,
p
= 0.0819). There was no significant difference in AF burden assessed by TTM versus Holter ECG recordings 3.1 ± 0.14% vs 4.8 ± 0.2%,
p
= 0.21.
Conclusions
Compared with Holter ECG, daily 30-s ECG recordings detected more patients with AF recurrences. Time to first detected AF episode tended to be shorter using TTM. Daily ECG recordings transmitted using smartphone may replace standard Holter ECG in detecting AF after ablation.
Trial registration
Clinical Trials Identifier: NCT03877913</description><identifier>ISSN: 1383-875X</identifier><identifier>ISSN: 1572-8595</identifier><identifier>EISSN: 1572-8595</identifier><identifier>DOI: 10.1007/s10840-022-01166-4</identifier><identifier>PMID: 35244820</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Ablation ; Aged ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - surgery ; Cardiac arrhythmia ; Cardiology ; Catheter Ablation ; Clinical trials ; Electrocardiography ; Electrocardiography, Ambulatory ; Female ; Fibrillation ; Humans ; Medicine ; Medicine & Public Health ; Middle Aged ; Monitoring ; Patients ; Quality assessment ; Recurrence ; Telemedicine ; Treatment Outcome</subject><ispartof>Journal of interventional cardiac electrophysiology, 2022-11, Vol.65 (2), p.373-380</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-505badb3bf7cb89c62e9cd7e074a8c3e82b41af6edf5a5fe1a24d98f5f3c9fb13</citedby><cites>FETCH-LOGICAL-c474t-505badb3bf7cb89c62e9cd7e074a8c3e82b41af6edf5a5fe1a24d98f5f3c9fb13</cites><orcidid>0000-0001-6818-2830</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10840-022-01166-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10840-022-01166-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35244820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sikorska, Agnieszka</creatorcontrib><creatorcontrib>Baran, Jakub</creatorcontrib><creatorcontrib>Piotrowski, Roman</creatorcontrib><creatorcontrib>Kryński, Tomasz</creatorcontrib><creatorcontrib>Szymot, Joanna</creatorcontrib><creatorcontrib>Soszyńska, Małgorzata</creatorcontrib><creatorcontrib>Kułakowski, Piotr</creatorcontrib><title>Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study</title><title>Journal of interventional cardiac electrophysiology</title><addtitle>J Interv Card Electrophysiol</addtitle><addtitle>J Interv Card Electrophysiol</addtitle><description>Purpose
To compare daily ECG transmissions using trans-telephonic monitoring (TTM) with repeated 6-day Holter ECG in detecting atrial fibrillation (AF) episodes following ablation.
Methods
Each patient underwent two types of recordings: daily ECG TTM lasting 30 s and standard 6-day ambulatory ECG monitoring performed 3, 6, and 12 months after ablation. Number of patients with detected AF recurrences, time to first detected recurrence of AF, and AF burden were assessed.
Results
Fifty patients (9 females, mean age 57 ± 11 years) were included. The mean duration of the follow-up was 382 ± 38 days. A total of 17,573 (mean 351 ± 111 per patient) TTM recordings were performed and 99.95% of recordings were of quality sufficient to assess cardiac rhythm. Altogether, 14 (28%) patients had AF recurrence. Holter ECG detected AF recurrence in 7 (14%) patients whereas TTM — in 12 (24%) patients,
p
= 0.0416 (TTM only — 7 (14%), Holter ECG only — 2 (4%), and both methods — 5 (10%)). Time to the first AF recurrence tended to be shorter using TTM than Holter ECG (156 ± 91 vs 204 ± 121 days,
p
= 0.0819). There was no significant difference in AF burden assessed by TTM versus Holter ECG recordings 3.1 ± 0.14% vs 4.8 ± 0.2%,
p
= 0.21.
Conclusions
Compared with Holter ECG, daily 30-s ECG recordings detected more patients with AF recurrences. Time to first detected AF episode tended to be shorter using TTM. Daily ECG recordings transmitted using smartphone may replace standard Holter ECG in detecting AF after ablation.
Trial registration
Clinical Trials Identifier: NCT03877913</description><subject>Ablation</subject><subject>Aged</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - surgery</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Catheter Ablation</subject><subject>Clinical trials</subject><subject>Electrocardiography</subject><subject>Electrocardiography, Ambulatory</subject><subject>Female</subject><subject>Fibrillation</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Monitoring</subject><subject>Patients</subject><subject>Quality assessment</subject><subject>Recurrence</subject><subject>Telemedicine</subject><subject>Treatment Outcome</subject><issn>1383-875X</issn><issn>1572-8595</issn><issn>1572-8595</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kctu1DAUhiMEoqXwAiyQJTZsDL7H2SBV02GKVMECkNhZjmO3rjJx8UkqZccjsOAJeRKcmaFcFqx85PP5s4__qnpKyUtKSP0KKNGCYMIYJpQqhcW96pjKmmEtG3m_1FxzrGv5-ah6BHBNCGkIUw-rIy6ZEJqR4-rbmY39jNarDRqzHWAbAWIa0K3PMAECn6PtkcKdndF56kefd2xIGY1XHlkAD7D1w4hSQD6E6Kybl9q2vR0X04LacacJsc2xP-z_-Pp9pzjdvFt_wIsUxqmbH1cPgu3BPzmsJ9WnN-uPq3N88X7zdnV6gZ2oxYglka3tWt6G2rW6cYr5xnW1J7Ww2nGvWSuoDcp3QVoZPLVMdI0OMnDXhJbyk-r13nsztVvfuTJCtr25yXFr82ySjebvzhCvzGW6NVo3QvO6CF4cBDl9mTyMpvyd82W8wacJDFNcUSGEYgV9_g96naY8lPEMqzlrKCNEFortKZcTQPbh7jGUmCVwsw_clMDNLnAjyqFnf45xd-RXwgXgewBKa7j0-ffd_9H-BFhKuYI</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Sikorska, Agnieszka</creator><creator>Baran, Jakub</creator><creator>Piotrowski, Roman</creator><creator>Kryński, Tomasz</creator><creator>Szymot, Joanna</creator><creator>Soszyńska, Małgorzata</creator><creator>Kułakowski, Piotr</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6818-2830</orcidid></search><sort><creationdate>20221101</creationdate><title>Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study</title><author>Sikorska, Agnieszka ; Baran, Jakub ; Piotrowski, Roman ; Kryński, Tomasz ; Szymot, Joanna ; Soszyńska, Małgorzata ; Kułakowski, Piotr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-505badb3bf7cb89c62e9cd7e074a8c3e82b41af6edf5a5fe1a24d98f5f3c9fb13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ablation</topic><topic>Aged</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - surgery</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Catheter Ablation</topic><topic>Clinical trials</topic><topic>Electrocardiography</topic><topic>Electrocardiography, Ambulatory</topic><topic>Female</topic><topic>Fibrillation</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Monitoring</topic><topic>Patients</topic><topic>Quality assessment</topic><topic>Recurrence</topic><topic>Telemedicine</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sikorska, Agnieszka</creatorcontrib><creatorcontrib>Baran, Jakub</creatorcontrib><creatorcontrib>Piotrowski, Roman</creatorcontrib><creatorcontrib>Kryński, Tomasz</creatorcontrib><creatorcontrib>Szymot, Joanna</creatorcontrib><creatorcontrib>Soszyńska, Małgorzata</creatorcontrib><creatorcontrib>Kułakowski, Piotr</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of interventional cardiac electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sikorska, Agnieszka</au><au>Baran, Jakub</au><au>Piotrowski, Roman</au><au>Kryński, Tomasz</au><au>Szymot, Joanna</au><au>Soszyńska, Małgorzata</au><au>Kułakowski, Piotr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study</atitle><jtitle>Journal of interventional cardiac electrophysiology</jtitle><stitle>J Interv Card Electrophysiol</stitle><addtitle>J Interv Card Electrophysiol</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>65</volume><issue>2</issue><spage>373</spage><epage>380</epage><pages>373-380</pages><issn>1383-875X</issn><issn>1572-8595</issn><eissn>1572-8595</eissn><abstract>Purpose
To compare daily ECG transmissions using trans-telephonic monitoring (TTM) with repeated 6-day Holter ECG in detecting atrial fibrillation (AF) episodes following ablation.
Methods
Each patient underwent two types of recordings: daily ECG TTM lasting 30 s and standard 6-day ambulatory ECG monitoring performed 3, 6, and 12 months after ablation. Number of patients with detected AF recurrences, time to first detected recurrence of AF, and AF burden were assessed.
Results
Fifty patients (9 females, mean age 57 ± 11 years) were included. The mean duration of the follow-up was 382 ± 38 days. A total of 17,573 (mean 351 ± 111 per patient) TTM recordings were performed and 99.95% of recordings were of quality sufficient to assess cardiac rhythm. Altogether, 14 (28%) patients had AF recurrence. Holter ECG detected AF recurrence in 7 (14%) patients whereas TTM — in 12 (24%) patients,
p
= 0.0416 (TTM only — 7 (14%), Holter ECG only — 2 (4%), and both methods — 5 (10%)). Time to the first AF recurrence tended to be shorter using TTM than Holter ECG (156 ± 91 vs 204 ± 121 days,
p
= 0.0819). There was no significant difference in AF burden assessed by TTM versus Holter ECG recordings 3.1 ± 0.14% vs 4.8 ± 0.2%,
p
= 0.21.
Conclusions
Compared with Holter ECG, daily 30-s ECG recordings detected more patients with AF recurrences. Time to first detected AF episode tended to be shorter using TTM. Daily ECG recordings transmitted using smartphone may replace standard Holter ECG in detecting AF after ablation.
Trial registration
Clinical Trials Identifier: NCT03877913</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35244820</pmid><doi>10.1007/s10840-022-01166-4</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6818-2830</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1383-875X |
| ispartof | Journal of interventional cardiac electrophysiology, 2022-11, Vol.65 (2), p.373-380 |
| issn | 1383-875X 1572-8595 1572-8595 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8894837 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Ablation Aged Atrial Fibrillation - diagnosis Atrial Fibrillation - surgery Cardiac arrhythmia Cardiology Catheter Ablation Clinical trials Electrocardiography Electrocardiography, Ambulatory Female Fibrillation Humans Medicine Medicine & Public Health Middle Aged Monitoring Patients Quality assessment Recurrence Telemedicine Treatment Outcome |
| title | Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A00%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Daily%20ECG%20transmission%20versus%20serial%206-day%20Holter%20ECG%20for%20the%20assessment%20of%20efficacy%20of%20ablation%20for%20atrial%20fibrillation%20%E2%80%94%20the%20AGNES-ECG%20study&rft.jtitle=Journal%20of%20interventional%20cardiac%20electrophysiology&rft.au=Sikorska,%20Agnieszka&rft.date=2022-11-01&rft.volume=65&rft.issue=2&rft.spage=373&rft.epage=380&rft.pages=373-380&rft.issn=1383-875X&rft.eissn=1572-8595&rft_id=info:doi/10.1007/s10840-022-01166-4&rft_dat=%3Cproquest_pubme%3E2732912005%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2732912005&rft_id=info:pmid/35244820&rfr_iscdi=true |